Bruce Bennett
#179,874
Most Influential Person Now
Bruce Bennett's AcademicInfluence.com Rankings
Bruce Bennettphilosophy Degrees
Philosophy
#11228
World Rank
#15433
Historical Rank
Logic
#8039
World Rank
#10002
Historical Rank
Bruce Bennettbiology Degrees
Biology
#15005
World Rank
#18897
Historical Rank
Molecular Biology
#2565
World Rank
#2606
Historical Rank
Biochemistry
#2633
World Rank
#2809
Historical Rank
Download Badge
Philosophy Biology
Bruce Bennett's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is Bruce Bennett Influential?
(Suggest an Edit or Addition)Bruce Bennett's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Plasminogen activator inhibitor (PAI‐1) in plasma and platelets (1988) (330)
- Distribution of plasminogen activator inhibitor (PAI-1) in tissues. (1991) (145)
- Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. (1996) (125)
- Changes in antihemophilic factor (AHF, factor 8) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography. (1972) (120)
- The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u‐PA rather than defibrination (1989) (107)
- Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1. (1987) (107)
- Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator. (1984) (97)
- Familial thrombosis: inherited deficiency of antithrombin III. (1978) (95)
- Proteins of the Fibrinolytic System in Human Thrombi (1996) (90)
- Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia. (1972) (90)
- Lysis of Platelet‐rich Thrombi: The Role of PAI–1 a (1992) (79)
- Platelet release protein which inhibits plasminogen activators. (1985) (78)
- The Roles of α2-Antiplasmin and Plasminogen Activator Inhibitor 1 (PAI-1) in the Inhibition of Clot Lysis (1993) (76)
- Plasminogen activator inhibitors (PAI‐1 and PAI‐2) in normal pregnancies, pre‐eclampsia and hydatidiform mole (1993) (74)
- Thrombi Formed in a Chandler Loop Mimic Human Arterial Thrombi in Structure and PAI-1 Content and Distribution (1997) (66)
- Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u‐PA‐dependent mechanism (2001) (58)
- Detection of the carrier state for classic hemophilia. (1973) (55)
- Outcome in colorectal adenocarcinoma: two seven-year studies of a population. (1993) (51)
- A new life-long hemorrhagic disorder due to excess plasminogen activator (1983) (50)
- The platelet and plasma pools of plasminogen activator inhibitor (PAI‐1) vary independently in disease (1990) (49)
- Diagnosis of deep vein thrombosis using autologous indium-III-labelled platelets. (1981) (49)
- Plasminogen activator inhibitor 2 and urokinase‐type plasminogen activator in plasma and leucocytes in patients with severe sepsis (2000) (48)
- Familial antithrombin III deficiency. (1982) (48)
- Clues to the pathogenesis of bleeding in von Willebrand's disease. (1973) (48)
- Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor. (1990) (47)
- Plasma nitrate concentrations in neutropenic and non‐neutropenic patients with suspected septicaemia (1995) (46)
- Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease. (1994) (45)
- p53 mutation and expression in lymphoma. (1995) (45)
- Frequency of venous thrombosis in patients with an exacerbation of chronic obstructive lung disease. (1983) (44)
- Plasminogen activator inhibitor from human endothelial cells (1987) (44)
- Plasmin‐a2‐antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis (1984) (44)
- Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. (1978) (43)
- The genetics of hereditary disorders of blood coagulation. (1973) (41)
- Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system. (1991) (41)
- Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas. (1973) (41)
- p53 mutation in the myelodysplastic syndromes (1995) (38)
- Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques. (1972) (38)
- The activity of plasminogen activator inhibitor-1 (PAI-1) of human platelet (1990) (38)
- Confirmation of linkage between antithrombin III and Duffy blodd group and assignment of AT3 to 1q22 → q25 (1982) (35)
- The inhibition of urokinase by alpha 2 -macroglobulin. (1973) (35)
- Haemostasis : biochemistry, physiology, and pathology (1977) (34)
- Polymorphonuclear Leucocytes Have Two Opposing Roles in Fibrinolysis (2002) (34)
- Streptokinase in iliofemoral venous thrombosis (1969) (33)
- Fibrinolysis and thrombosis. (1994) (31)
- Studies on the regulation of granulopoiesis. II. Relationship to other differentiation pathways. (1970) (29)
- Fertility in young men and women after treatment for lymphoma: a study of a population. (1985) (29)
- Plasminogen activator inhibitors (PAI‐1 and PAI‐2) in normal pregnancies, pre‐eclampsia and hydatidiform mole (1994) (27)
- Properties of a partially purified preparation of a circulating plasminogen activator. (1976) (26)
- Haemoglobin concentration and linear cardiac output, peripheral resistance, and oxygen transport. (1986) (26)
- The receptor for tissue plasminogen activator (t‐PA) in complex with its inhibitor, PAI‐1, on human hepatocytes (1991) (25)
- The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness. (1975) (25)
- High grade non‐Hodgkins lymphoma in the elderly—12 year experience in the grampian region of scotland (1995) (24)
- Comparative Studies on Human Activators of Plasminogen (1981) (24)
- Inhibitors of Plasminogen Activator in Neutrophils and Mononuclear Cells from Septic Patients (1995) (23)
- The normal coagulation mechanism. (1972) (22)
- A new life-long hemorrhagic disorder due to excess plasminogen activator. (1983) (22)
- Measurement of platelet life‐span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets (1984) (22)
- The plasma inhibitors of plasminogen activator, studied by a zymographic technique. (1985) (21)
- PLASMIN‐α2‐ANTIPLASMIN COMPLEX AS AN INDICATOR OF IN VIVO FIBRINOLYSIS (1982) (21)
- Transfusion Studies in Patients with Familial Antithrombin III (ATIII) Deficiency: Half‐disappearance Time of Infused ATIII and Influence of such Infusion on Platelet Life‐span (1981) (20)
- Hageman trait (factor XII deficiency): a probably second genotype inherited as an autosomal dominant characteristic. (1972) (20)
- A Plasminogen Activator Inhibitor (PAI-2) Circulates in Two Molecular Forms During Pregnancy (1988) (20)
- Evidence for an active fibrinolytic system in normal human bone marrow (1996) (18)
- Effect of local exercise and vessel occlusion on fibrinolytic activity. (1977) (18)
- Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases. (1994) (18)
- Haemostatic response to trauma. (1985) (17)
- Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leucopenia (1995) (16)
- Immunologic Relationships of Antihemophilic Factor of Different Species Detected by Specific Human and Rabbit Antibodies 1 (1973) (16)
- Indium-111 labelled platelets in diagnosis of leg-vein thrombosis: preliminary findings. (1980) (16)
- Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency (1984) (16)
- Treatment of venous thrombosis in antithrombin III deficient patients with concentrates of antithrombin III. (2008) (15)
- Thrombotic risks of staging laparotomy with splenectomy in Hodgkin's disease (1981) (15)
- Evidence for a seasonal variation in the presentation of Hodgkins disease. (1995) (14)
- SEVERE DEPLETION OF VITAMIN-K-DEPENDENT CLOTTING FACTORS DURING POSTOPERATIVE LATAMOXEF THERAPY (1983) (13)
- Plasminogen activator in acute myeloid leukaemic marrows: u‐PA in contrast to t‐PA in normal marrow (1998) (13)
- Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterization. (1987) (13)
- Inhibitors of Plasminogen Activation in Human Blood (1976) (12)
- Localization and Identification of Thrombin and Plasminogen Activator Activities in Model Human Thrombi by in situ Zymography (2002) (12)
- Splenectomy and infection in Hodgkin's disease (1983) (12)
- Diagnosis of avascular necrosis of the femoral head in patients treated for lymphoma (1995) (11)
- PREOPERATIVE FREQUENCY OF DEEP VENOUS THROMBOSIS IN PATIENTS WITH FRACTURED NECK OF FEMUR (1981) (10)
- Lipoprotein Fractions and Antithrombin III Consumption During Clotting (1982) (10)
- Immunophenotyping of leukaemias by flow cytometry and APAAP: a two-year comparative analysis in hospital practice. (1988) (9)
- Tumour cell u‐PA as a cause of fibrinolytic bleeding in metastatic disease (1997) (9)
- Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasmin. (2000) (9)
- Plasminogen activator inhibitor (PAI-2) in pregnancy plasma and ovarian cysts, studied by zymography after non-denaturing gel electrophoresis (1989) (9)
- Chronic lymphocytic leukaemia contemporaneous with HIV infection. (1987) (8)
- The fibrinolytic enzyme system in hypertension (1973) (8)
- HAEMODIALYSIS FOR A HAEMOPHILIAC WITH HUMAN IMMUNODEFICIENCY VIRUS (1988) (7)
- The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas. (1988) (7)
- Arterial thrombosis and accelerated atheroma in a member of a family with familial antithrombin III deficiency (1982) (6)
- Antigen-biological-activity ratio for factor VIII. (1973) (6)
- Haemorrhage associated with large abdominal aortic aneurysms. (2008) (6)
- Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA (1998) (6)
- The value of autologous indium (111In)-labelled platelets in the diagnosis of renal transplant rejection. (1984) (6)
- Myeloid leukaemic cells can lyse fibrin directly. (2000) (6)
- Polymorphonuclear leukocytes from patients with severe sepsis have lost the ability to degrade fibrin via u‐PA (2004) (5)
- FACTORS INFLUENCING THROMBOSIS IN FAMILIAL ANTITHROMBIN III DEFICIENCY (1983) (5)
- Diagnosis of aortic aneurysm using autologous platelets labelled with indium-111. (1981) (5)
- Detection of Carriers of Classic Haemophilia (1973) (5)
- Effect of low-density lipoprotein preparations on plasmin. (1973) (5)
- 251 Tissue concentrations of the inhibitor of plasminogen activatory , PAI-1 (1988) (4)
- Effective lysis of model thrombi by a t‐PA mutant (A473S) that is resistant to α2‐antiplasmin (2000) (4)
- Coagulation pathways: interrelationships and control mechanisms. (1977) (4)
- Thrombosis after venography in familial antithrombin II deficiency. (1981) (4)
- Confirmation of linkage between antithrombin III and Duffy blood group and assignment of AT3 to 1q22 lead to q25. (1982) (4)
- Aortic thrombosis in antithrombin III deficiency. (1982) (3)
- Myeloid leukaemic cells can lyse fibrin directly (2000) (3)
- Plasmin--alpha 2-antiplasmin complex as an indicator of in vivo fibrinolysis. (1982) (3)
- Localisation and quantification of proteins of the fibrinolytic system in normal and atherosclerotic vessels (1994) (3)
- Haemodialysis for a haemophiliac with immunodeficiency virus. (1988) (2)
- HEMOPHILIA A AND VON WILLEBRAND'S DISEASE: THE RELATIONSHIP EXAMINED (1975) (2)
- Application of immunological techniques to the study of classic haemophilia and von Willebrand's disease. (1973) (2)
- Anti-haemophilic factor, normal and abnormal. (1974) (2)
- Distribution ofplasminogen activator inhibitor (PAI-1) intissues (1991) (2)
- The Antithrombin III Locus is Linked to the Duffy Blood Group and to Iqh. Assignment of AT3 to Iq22→Iq25 (1982) (2)
- Accelerated increase in aortic diameter in patients treated for lymphoma (2005) (2)
- Haemoglobin concentration and linear cardiac output, peripheral resistance, and oxygen transport (1986) (2)
- Familial Thrombosis Due to Antithrombin III Deficiency: An Extensive Family Study (1977) (1)
- Parvovirus B19 induced red cell aplasia in myelofibrosis (1993) (1)
- Plasminogen activators inalcoholic cirrhosis: demonstration ofincreased tissue typeandurokinase typeactivator (1984) (1)
- Measurement of platelet life span using indium 111 labeled platelets in normal subjects and patients with myelo proliferative disease (1983) (1)
- Stanozolol Treatment in Patients with Familial ATIII Deficiency (1982) (1)
- A study of thrombi formed in the Chandler loop (1995) (1)
- P17 Plasminogen activator inhibitor-2 (PAI-2) in plasma and white cells from normal and severely septicaemic subjects (1997) (0)
- Lysis of Chandler model thrombi is inhibited by both plasminogen activator inhibitor and ??2-antiplasmin (1996) (0)
- Haemostatic derangements and major sepsis (1997) (0)
- 64 Leucocyte and plasma PAs and PAIs in patients with cardiovascular collapse in sepsis (1997) (0)
- Studies on Circulating Plasminogen Activator (1975) (0)
- Preoperative antithrombin III activities and lipoprotein concentrations as predictors of venous thrombosis in patients with fracture of neck of femur. (1983) (0)
- Comparison of the Human Activators of Plasminogen (1979) (0)
- A PLASMINOGEN ACTIVATOR INHIBITOR (PAI-2) CIRCULATES IN TWO HIGH MOLECULAR WEIGHT FORMS IN PREGNANCY (1987) (0)
- A simple, non‐invasive method of assessing the acute hemodynamic effects of doxorubicin (2006) (0)
- Inhibition of proteolysis by leucocytes from patients with septicaemia (1995) (0)
- Proceedings: Studies on circulating plasminogen activator. (1975) (0)
- Association of Non-Hodgkin's Lymphoma of Stomach, and Colonic Carcinoma; Practical Implications for Management (1990) (0)
- Detection of Deep Vein Thrombosis Using 111Indium Labelled Platelets (1986) (0)
- Abstract Poster presentation P-13: Fibrinolysis in various disease statesPlasminogen activator inhibitor-1 (PAI-1) levels in neutropenic and non-neutropenic patients with major septicaemias (1994) (0)
- A Life-Long And Ultimately Fatal Bleeding Syndrome Due To Grossly Increased Levels Of Plasma Plasminogen Activator (1981) (0)
- 381 Plasminogen activator inhibitor (PAI-2) in ovarian cysts and pregnancy plasma (1988) (0)
- Properties of plasma plasminogen activators [proceedings]. (1978) (0)
- 73 PAI-1 in plasma and platelets (1988) (0)
- Arterial thrombosis andaccelerated atheroma inamemberofafamily withfamilial antithrombin IIIdeficiency (1982) (0)
- THE INHIBITION O F UROKINASE BY ALPHA ,-MACROGLOBULIN (2012) (0)
- Activators and inhibitors of fibrinolysis in normal human bone marrow (1995) (0)
- Leucocytes from patients with septicaemia enhance release of plasminogen activator inhibitor-1 (PAI-l) by endothelial cells (1995) (0)
- Properties of Plasminogen Activators in Circulating Human Blood and Human Cadaveric Veins (1977) (0)
- Unusual presentation of opportunistic infections in patients with leukemia: Identification of fungal lesions by ultrasound (1987) (0)
- Role of leukocytes in the suppression of fibrinolytic system in patients with septicaemia (1995) (0)
- STUDIES ON THE DETECTION OF THE CARRIER STATE OF CLASSIC HEMOPHILIA (FACTOR VIII DEFICIENCY) (1973) (0)
- Plasmin-α2Antiplasmin Complexes in Acquired Bleeding Disorders (1982) (0)
- 263 The fibrinolytic contribution to haemorrhage in classical dic and acute promyelocytic leukaemia (1988) (0)
- Human Plasminogen Activator From Heart And Vascular Endothelium (1981) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bruce Bennett?
Bruce Bennett is affiliated with the following schools:
